A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 1 X post from an account with 43 followers.

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients https://t.co/9s3wxQWrNR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.